Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

1.17
-0.5550-32.17%
Pre-market: 1.190.0200+1.71%05:12 EDT
Volume:11.69M
Turnover:13.45M
Market Cap:73.67M
PE:-0.98
High:1.30
Open:1.27
Low:1.06
Close:1.73
52wk High:3.82
52wk Low:1.06
Shares:62.96M
Float Shares:21.07M
Volume Ratio:9.00
T/O Rate:55.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:2.74
PE(LYR):-1.17

Loading ...

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 12

Simcere says China regulator accepts NDA for atopic dermatitis drug rademikibart

Reuters
·
Apr 30

Northland Securities Remains a Buy on Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 24

Connect Biopharma Holdings Ltd - Expects to Report Phase 2 Seabreeze Stat Topline Data in Mid-2026

THOMSON REUTERS
·
Apr 23

Connect Biopharma Holdings: Data Monitoring Committee Reports No Safety Concerns or Treatment-Related Serious Adverse Events in Seabreeze Stat Studies

THOMSON REUTERS
·
Apr 23

Connect Biopharma Holdings - Enrollment in Phase 2 Seabreeze Stat Studies Will Continue as Planned Following Pre-Specified Interim Analysis

THOMSON REUTERS
·
Apr 23

Connect Biopharma Seabreeze STAT Phase 2 trials continue unchanged after interim review

Reuters
·
Apr 23

Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 08

Connect Biopharma Price Target Maintained With a $10.00/Share by BTIG

Dow Jones
·
Apr 02

Connect Biopharma director James Huang acquires $4 million common shares

Reuters
·
Apr 02

Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Apr 01

Connect Biopharma Hldgs Q4 EPS $(0.27) Beats $(0.30) Estimate

Benzinga Earnings
·
Apr 01

Connect Biopharma FY25 net loss widens to $55.5 million; cash, investments fall to $44 million

Reuters
·
Apr 01

Press Release: Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

Dow Jones
·
Apr 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Mar 31

Connect Biopharma Price Target Maintained With a $10.00/Share by BTIG

Dow Jones
·
Mar 31

Connect Biopharma Shares Decline on Private Placement

Dow Jones
·
Mar 31

BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar

Reuters
·
Mar 30

Analysts Conflicted on These Healthcare Names: Connect Biopharma Holdings (CNTB), Neumora Therapeutics, Inc. (NMRA) and Merck & Company (MRK)

TIPRANKS
·
Mar 30

Connect Biopharma Announces Positive Topline Data From Its Phase 1 Study Of Intravenous (Iv) Rademikibart In Patients With Asthma Or Copd

Reuters
·
Mar 30